Louis Alexopoulos
Corporate Officer/Principal bij Sotos Associates
Profiel
Louis Alexopoulos is currently a Partner at Sotos Associates.
Previously, he worked as Secretary & Independent Director at Transition Therapeutics, Inc. from 2011 to 2012.
Actieve functies van Louis Alexopoulos
| Bedrijven | Functie | Begin |
|---|---|---|
Sotos Associates
 Sotos Associates Miscellaneous Commercial ServicesCommercial Services Sotos Associates operates as law firm. The company is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
Eerdere bekende functies van Louis Alexopoulos
| Bedrijven | Functie | Einde |
|---|---|---|
| TRANSITION THERAPEUTICS INC | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Medical SpecialtiesHealth Technology Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada. | Health Technology |
Sotos Associates
Sotos Associates Miscellaneous Commercial ServicesCommercial Services Sotos Associates operates as law firm. The company is headquartered in Toronto, Canada. | Commercial Services |
